Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
2.680
-0.020 (-0.74%)
At close: Jul 25, 2025, 4:00 PM
2.630
-0.050 (-1.87%)
After-hours: Jul 25, 2025, 7:45 PM EDT
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,846,400
Market Cap
133.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACHV News
- 1 day ago - Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025 - GlobeNewsWire
- 18 days ago - Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation - Seeking Alpha
- 25 days ago - Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades - GlobeNewsWire
- 7 weeks ago - Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk - Seeking Alpha
- 2 months ago - Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire